Generation of a µ-1,2-hydroperoxo FeIIIFeIII and a µ-1,2-peroxo FeIVFeIII Complex.

µ-1,2-Peroxo-diferric intermediates (P) of non-heme diiron enzymes are proposed to convert upon protonation either to high-valent active species or to activated P' intermediates via hydroperoxo-diferric intermediates. Protonation of synthetic µ-1,2-peroxo model complexes occurred at the µ-oxo and not at the µ-1,2-peroxo bridge. Here we report a stable µ-1,2-peroxo complex {FeIII(µ-O)(µ-1,2-O2)FeIII} using a dinucleating ligand and study its reactivity. The reversible oxidation and protonation of the µ-1,2-peroxo-diferric complex provide µ-1,2-peroxo FeIVFeIII and µ-1,2-hydroperoxo-diferric species, respectively. Neither the oxidation nor the protonation induces a strong electrophilic reactivity. Hence, the observed intramolecular C-H hydroxylation of preorganized methyl groups of the parent µ-1,2-peroxo-diferric complex should occur via conversion to a more electrophilic high-valent species. The thorough characterization of these species provides structure-spectroscopy correlations allowing insights into the formation and reactivities of hydroperoxo intermediates in diiron enzymes and their conversion to activated P' or high-valent intermediates.

Catalytic H2O2 Activation by a Diiron Complex for Methanol Oxidation.

In nature, C-H bond oxidation of CH4 involves a peroxo intermediate that decays to the high-valent active species of either a "closed" {FeIV(µ-O)2FeIV} core or an "open" {FeIV(O)(µ-O)FeIV(O)} core. To mimic and to obtain more mechanistic insight in this reaction mode, we have investigated the reactivity of the bioinspired diiron complex [(susan){Fe(OH)(µ-O)Fe(OH)}]2+ [susan = 4,7-dimethyl-1,1,10,10-tetrakis(2-pyridylmethyl)-1,4,7,10-tetraazadecane], which catalyzes CH3OH oxidation with H2O2 to HCHO and HCO2H. The kinetics is faster in the presence of a proton. 18O-labeling experiments show that the active species, generated by a decay of the initially formed peroxo intermediate [(susan){FeIII(µ-O)(µ-O2)FeIII}]2+, contains one reactive oxygen atom from the µ-oxo and another from the µ-peroxo bridge of its peroxo precursor. Considering an FeIVFeIV active species, a "closed" {FeIV(µ-O)2FeIV} core explains the observed labeling results, while a scrambling of the terminal and bridging oxo ligands is required to account for an "open" {FeIV(O)(µ-O)FeIV(O)} core.

Two Unsupported Terminal Hydroxido Ligands in a µ-Oxo-Bridged Ferric Dimer: Protonation and Kinetic Lability Studies.

The dinuclear complex [(susan){FeIII(OH)(µ-O)FeIII(OH)}](ClO4)2 (Fe2(OH)2(ClO4)2; susan = 4,7-dimethyl-1,1,10,10-tetra(2-pyridylmethyl)-1,4,7,10-tetraazadecane) with two unsupported terminal hydroxido ligands and for comparison the fluorido-substituted complex [(susan){FeIIIF(µ-O)FeIIIF}](ClO4)2 (Fe2F2(ClO4)2) have been synthesized and characterized in the solid state as well in acetonitrile (CH3CN) and water (H2O) solutions. The Fe-OH bonds are strongly modulated by intermolecular hydrogen bonds (1.85 and 1.90 Å). UV-vis-near-IR (NIR) and Mössbauer spectroscopies prove that Fe2F22+ and Fe2(OH)22+ retain their structural integrity in a CH3CN solution. The OH- ligand induces a weaker ligand field than the F- ligand because of stronger π donation. This increased electron donation shifts the potential for the irreversible oxidation by 610 mV cathodically from 1.40 V in Fe2F22+ to 0.79 V versus Fc+/Fc in Fe2(OH)22+. Protonation/deprotonation studies in CH3CN and aqueous solutions of Fe2(OH)22+ provide two reversible acid-base equilibria. UV-vis-NIR, Mössbauer, and cryo electrospray ionization mass spectrometry experiments show conservation of the mono(µ-oxo) bridging motif, while the terminal OH- ligands are protonated to H2O. Titration experiments in aqueous solution at room temperature provide the p Ka values as p K1 = 4.9 and p K2 = 6.8. Kinetic studies by temperature- and pressure-dependent 17O NMR spectrometry revealed for the first time the water-exchange parameters [ kex298 = (3.9 ± 0.2) × 105 s-1, Δ H⧧ = 39.6 ± 0.2 kJ mol-1, Δ S⧧ = -5.1 ± 1 J mol-1 K-1, and Δ V⧧ = +3.0 ± 0.2 cm3 mol-1] and the underlying Id mechanism for a {FeIII(OH2)(µ-O)FeIII(OH2)} core. The same studies suggest that in solution the monoprotonated {FeIII(OH)(µ-O)FeIII(OH2)} complex has µ-O and µ-O2H3 bridges between the two Fe centers.

Reversible Carboxylate Shift in a µ-Oxo Diferric Complex in Solution by Acid-/Base-Addition.

A reversible carboxylate shift has been observed in a µ-oxo diferric complex in solution by UV-vis-NIR and FTIR spectroscopy triggered by the addition of a base or an acid. A terminal acetate decoordinates upon the addition of a proton, resulting in a shift of the remaining terminal acetato to a µ-η1:η1 bridge. The addition of a base restores the original structure containing only terminal acetates. The implications for metalloenzymes with carboxylate-bridged nonheme diiron active sites are discussed.

A Mixed-Valence Fluorido-Bridged FeIIFeIII Complex.

The reaction of the new dinucleating ligand susan6-Me with Fe(BF4)2·6H2O results in formation of the homovalent FeIIFeII complex [(susan6-Me){FeII(µ-F)2FeII}]2+ and the mixed-valence FeIIFeIII complex [(susan6-Me){FeIIF(µ-F)FeIIIF}]2+ depending on the absence or presence of dioxygen, respectively. Complex [(susan6-Me){FeIIF(µ-F)FeIIIF}]2+ is the first molecular mixed-valence complex with a fluorido bridge. The short FeIII-µ-F bond of 1.87 Å causes a large reorganization energy, resulting in a localized class II system with an intervalence charge-transfer band of high energy at 10000 cm-1.

Design and synthesis of a dinucleating ligand system with varying terminal donor functions that provides no bridging donor and its application to the synthesis of a series of Fe(III)-µ-O-Fe(III) complexes.

Based on a rational ligand design for stabilizing high-valent {Fe(µ-O)2Fe} cores, a new family of dinucleating bis(tetradentate) ligands with varying terminal donor functions has been developed: redox-inert biomimetic carboxylates in H4julia, pyridines in susan, and phenolates in H4hilde(Me2). Based on a retrosynthetic analysis, the ligands were synthesized and used for the preparation of their diferric complexes [(julia){Fe(OH2)(µ-O)Fe(OH2)}]·6H2O, [(julia){Fe(OH2)(µ-O)Fe(OH2)}]·7H2O, [(julia){Fe(DMSO)(µ-O)Fe(DMSO)}]·3DMSO, [(hilde(Me2)){Fe(µ-O)Fe}]·CH2Cl2, [(hilde(Me2)){FeCl}2]·2CH2Cl2, [(susan){FeCl(µ-O)FeCl}]Cl2·2H2O, [(susan){FeCl(µ-O)FeCl0.75(OCH3)0.25}](ClO4)2·0.5MeOH, and [(susan){FeCl(µ-O)FeCl}](ClO4)2·0.5EtOH, which were characterized by single-crystal X-ray diffraction, FTIR, UV-Vis-NIR, Mössbauer, magnetic, and electrochemical measurements. The strongly electron-donating phenolates afford five-coordination, while the carboxylates and pyridines lead to six-coordination. The analysis of the ligand conformations demonstrates a strong flexibility of the ligand backbone in the complexes. The different hydrogen-bonding in the secondary coordination sphere of [(julia){Fe(OH2)(µ-O)Fe(OH2)}] influences the C-O, C[double bond, length as m-dash]O, and Fe-O bond lengths and is reflected in the FTIR spectra. The physical properties of the central {Fe(µ-O)Fe} core (d-d, µ-oxo → Fe(III) CT, νas(Fe-O-Fe), J) are governed by the differences in terminal ligands - Fe(III) bonds: strongly covalent π-donation with phenolates, less covalent π-donation with carboxylates, and π-acceptation with pyridines. Thus, [(susan){FeCl(µ-O)FeCl}](2+) is oxidized at 1.48 V vs. Fc(+)/Fc, which is shifted to 1.14 V vs. Fc(+)/Fc by methanolate substitution, while [(julia){Fe(OH2)(µ-O)Fe(OH2)}] is oxidized ≤1 V vs. Fc(+)/Fc. [(hilde(Me2)){Fe(µ-O)Fe}] is oxidized at 0.36 V vs. Fc(+)/Fc to a phenoxyl radical. The catalytic oxidation of cyclohexane with TONs up to 39.5 and 27.0 for [(susan){FeCl(µ-O)FeCl}](2+) and [(hilde(Me2)){Fe(µ-O)Fe}], respectively, indicates the potential to form oxidizing intermediates.